Skip to main content
Livermore
Livermore
ZHEN

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

KALV holding history

KalVista Pharmaceuticals, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KALV overviewAll 13F holders of KALVFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of KALV by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−1,955,844−100.0%Sold outHolders
Q1 20261,955,844$39.4M<0.1%+44,153+2.3%AddedHolders
Q4 20251,911,691$30.9M<0.1%+336,195+21.3%AddedHolders
Q3 20251,575,496$19.2M<0.1%+225,957+16.7%AddedHolders
Q2 20251,349,539$15.3M<0.1%+255,896+23.4%AddedHolders
Q1 20251,093,643$12.6M<0.1%−297,220−21.4%ReducedHolders
Q4 20241,390,863$11.8M<0.1%+119,254+9.4%AddedHolders
Q3 20241,271,609$14.7M<0.1%+515,179+68.1%AddedHolders
Q2 2024756,430$8.91M<0.1%+162,257+27.3%AddedHolders
Q1 2024594,173$7.05M<0.1%+57,071+10.6%AddedHolders
Q4 2023537,102$6.58M<0.1%+77,756+16.9%AddedHolders
Q3 2023459,346$4.42M<0.1%+13,171+3.0%AddedHolders
Q2 2023446,175$4.02M<0.1%+26,914+6.4%AddedHolders
Q1 2023419,261$3.30M<0.1%+15,301+3.8%AddedHolders
Q4 2022403,960$2.73M<0.1%−17,859−4.2%ReducedHolders
Q3 2022421,819$6.12M<0.1%+11,567+2.8%AddedHolders
Q2 2022410,252$4.04M<0.1%−528,615−56.3%ReducedHolders
Q1 2022938,867$13.8M<0.1%−113,109−10.8%ReducedHolders
Q4 20211,051,976$13.9M<0.1%+8,148+0.8%AddedHolders
Q3 20211,043,828$18.2M<0.1%−356,673−25.5%ReducedHolders
Q2 20211,400,501$33.6M<0.1%+809,029+136.8%AddedHolders
Q1 2021591,472$15.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.